Apollomics (APLM) Cash & Current Investments (2020 - 2025)

Apollomics (APLM) posted quarterly Cash & Current Investments of $3.3 million for Q4 2025, down 66.46% year-on-year from $9.8 million in Q4 2024, and up 56.45% on a QoQ basis from $2.1 million in Q2 2025.

Apollomics (APLM) Cash & Current Investments (2020 - 2025) Analysis & Trends

Apollomics (APLM) has reported Cash & Current Investments for 6 consecutive years, with $3.3 million the latest figure, recorded in Q4 2025.

  • Quarterly Cash & Current Investments fell 66.46% year-over-year to $3.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $3.3 million (down 66.46% YoY) and the FY2025 annual result came in at $3.3 million, down 66.46% from the prior year.
  • Cash & Current Investments advanced to $3.3 million in Q4 2025 per APLM's latest filing, from $2.1 million in the prior quarter.
  • Over the last five years, Cash & Current Investments for APLM reached as high as $51.7 million in Q4 2022 and fell as low as $2.1 million in Q2 2025.
  • A 5-year average of $28.6 million and a median of $30.2 million in 2021 frame the typical range for Cash & Current Investments.
  • Annual changes were most pronounced in 2022 — Cash & Current Investments surged 71.16% — and 2025, when it sank 91.92%.
  • Year by year, Cash & Current Investments stood at $30.2 million in 2021, then jumped by 71.16% to $51.7 million in 2022, then dropped by 26.91% to $37.8 million in 2023, then sank by 74.18% to $9.8 million in 2024, then sank by 66.46% to $3.3 million in 2025.
  • According to Business Quant data, Cash & Current Investments over the past three periods registered $3.3 million, $2.1 million, and $9.8 million for Q4 2025, Q2 2025, and Q4 2024 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 283.54 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 61.40 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 4.79 Bn
4 NuCana 279.75 Bn 279.75 Bn - 32.26 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 7.25 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 8.75 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 5.18 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Apollomics 2.66 Bn 2.66 Bn - 3.28 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 3.28 Mn
Jun 30, 2025 2.09 Mn
Dec 31, 2024 9.77 Mn
Jun 30, 2024 25.93 Mn
Dec 31, 2023 37.82 Mn
Jun 30, 2023 45.70 Mn
Dec 31, 2022 51.74 Mn
Jun 30, 2022 50.70 Mn
Dec 31, 2021 30.23 Mn
Dec 31, 2020 130.65 Mn